Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05259111 · ClinicalTrials.gov registry record · NA

Home Hospital for Bariatric Sleeve Gastrectomy

A NA study of Bariatric Surgery Candidate and Bariatric Sleeve Gastrectomy, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
28
Enrollment target
2
Study locations

NCT05259111 is a NA study of Bariatric Surgery Candidate and Bariatric Sleeve Gastrectomy that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 28 participants, below the 112-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05259111, a NA study of Bariatric Surgery Candidate and Bariatric Sleeve Gastrectomy, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
2
Study locations

Study Summary

Providing acute care at home for medicine patients is a well-studied care model. Providing acute care at home immediately following major surgery is less well understood. The investigators seek to demonstrate the noninferiority of care at home versus the hospital for patients undergoing bariatric sleeve gastrectomy.

Interventions

  • OTHER Home hospital

Study Locations (2)

Massachusetts

  • Brigham and Women's Faulkner Hospital - Boston
  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2022-02-23
Est. Completion 2024-05-24
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT05259111

The ClinicalTrials.gov registry entry for NCT05259111 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (75% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Bariatric Surgery Candidate appearing as the primary indexed condition, and to 1 intervention - of which Home hospital is the first listed.

NCT05259111 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05259111 about?

NCT05259111 is a clinical study titled "Home Hospital for Bariatric Sleeve Gastrectomy". Providing acute care at home for medicine patients is a well-studied care model. Providing acute care at home immediately following major surgery is less well understood. The investigators seek to demonstrate the noninferiority of care at home versus the hospital for patients undergoing bariatric sl...

What is the current status of trial NCT05259111?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-02-23. Estimated completion is 2024-05-24.

What conditions does trial NCT05259111 study?

This clinical trial studies the following conditions: Bariatric Surgery Candidate, Bariatric Sleeve Gastrectomy, Home Hospital.

What interventions are being tested in trial NCT05259111?

The interventions under investigation include: Home hospital (OTHER).

Who is sponsoring clinical trial NCT05259111?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05259111 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bariatric Surgery Candidate

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.